BDBM361955 N-[(1S)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]carbonyl}-2-methylpropyl]-9- ethyl-8-(2-methylpyrimidin-5-yl)- 9H-purin-6-amine::US10221178, Compound 2-49
SMILES: CCn1c(nc2c(N[C@@H](C(C)C)C(=O)N3C[C@H](C)O[C@H](C)C3)ncnc12)-c1cnc(C)nc1
InChI Key: InChIKey=GFXSIGJYZMLGSM-DAYGRLMNSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens (Human)) | BDBM361955 (N-[(1S)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]car...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column... | US Patent US10221178 (2019) BindingDB Entry DOI: 10.7270/Q20C4Z2D | |||||||||||
More data for this Ligand-Target Pair |